BIIB
Biogen Inc
Price:  
133.06 
USD
Volume:  
1,331,027.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biogen Relative Valuation

39.5%
Upside

As of 2025-06-12, the Relative Valuation of Biogen Inc (BIIB) is 185.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 133.06 USD, the upside of Biogen Inc based on Relative Valuation is 39.5%.

The range of the Relative Valuation is 139.08 - 241.82 USD.

Range Selected
Trailing P/E multiples 15.1x - 21.0x 18.6x
Forward P/E multiples 11.9x - 20.8x 15.8x
Fair Price 139.08 - 241.82 185.62
Upside 4.5% - 81.7% 39.5%
133.06 USD
Stock Price
185.62 USD
Fair Price

Biogen Relative Valuation - Historical P/E Data

Date P/E
2025-06-11 13.18
2025-06-10 13.42
2025-06-09 13.29
2025-06-06 13.19
2025-06-05 12.91
2025-06-04 13.06
2025-06-03 13.06
2025-06-02 12.99
2025-05-30 12.86
2025-05-29 13.15
2025-05-28 12.63
2025-05-27 12.72
2025-05-23 12.46
2025-05-22 12.51
2025-05-21 12.56
2025-05-20 12.93
2025-05-19 12.82
2025-05-16 12.44
2025-05-15 12.25
2025-05-14 11.92
2025-05-13 12.20
2025-05-12 12.32
2025-05-09 11.71
2025-05-08 11.73
2025-05-07 11.61
2025-05-06 11.57
2025-05-05 12.06
2025-05-02 12.24
2025-05-01 11.98
2025-04-30 11.99
2025-04-29 11.90
2025-04-28 11.80
2025-04-25 11.77
2025-04-24 11.84
2025-04-23 11.71
2025-04-22 11.78
2025-04-21 11.54
2025-04-17 11.75
2025-04-16 11.42
2025-04-15 11.59
2025-04-14 11.81
2025-04-11 11.41
2025-04-10 11.23
2025-04-09 11.93
2025-04-08 11.30
2025-04-07 11.81
2025-04-04 12.18
2025-04-03 12.95
2025-04-02 13.01
2025-04-01 13.08